HHS Publishes Final Changes to HIPAA Privacy Rule
Client Alert | 1 min read | 08.15.02
On Wednesday, August 14, 2002, the Secretary of the Department of Health and Human Services ("HHS") published in the Federal Register revised Standards for Privacy of Individually Identifiable Health Information ("Final Rule") under the Health Insurance Portability and Accountability Act of 1996, P.L. 104-191 ("HIPAA"). Most health care entities must be fully compliant with the Final Rule by April 14, 2003. The changes set forth in the Final Rule modify privacy standards originally promulgated in December 2000 ("Privacy Rule"), and are substantially similar to changes to the Privacy Rule proposed by HHS in a March 2002 Notice of Proposed Rulemaking ("March NPRM"). The Final Rule - available at www.hhs.gov/ocr/hipaa - is intended "to maintain strong protections for the privacy of individually identifiable health information while clarifying certain of the Privacy Rule's provisions, addressing the unintended negative effects of the Privacy Rule on health care quality or access to health care, and relieving unintended administrative burdens created by the Privacy Rule." more...
Insights
Client Alert | 8 min read | 06.30.25
AI Companies Prevail in Path-Breaking Decisions on Fair Use
Last week, artificial intelligence companies won two significant copyright infringement lawsuits brought by copyright holders, marking an important milestone in the development of the law around AI. These decisions – Bartz v. Anthropic and Kadrey v. Meta (decided on June 23 and 25, 2025, respectively), along with a February 2025 decision in Thomson Reuters v. ROSS Intelligence – suggest that AI companies have plausible defenses to the intellectual property claims that have dogged them since generative AI technologies became widely available several years ago. Whether AI companies can, in all cases, successfully assert that their use of copyrighted content is “fair” will depend on their circumstances and further development of the law by the courts and Congress.
Client Alert | 3 min read | 06.30.25
Client Alert | 3 min read | 06.26.25
FDA Targets Gene Editing Clinical Trials in China and other “Hostile Countries”
Client Alert | 3 min read | 06.26.25
